GAMCO Investors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-15,891
| Closed | -$2.92M | – | 958 |
|
|
2021
Q2 | $2.92M | Sell |
15,891
-1,925
| -11% | -$354K | 0.02% | 454 |
|
|
2021
Q1 | $2.72M | Buy |
17,816
+10,916
| +158% | +$1.67M | 0.02% | 453 |
|
|
2020
Q4 | $1.08M | Buy |
+6,900
| New | +$1.08M | 0.01% | 599 |
|
|
2020
Q2 | – | Sell |
-9,000
| Closed | -$808K | – | 899 |
|
|
2020
Q1 | $808K | Hold |
9,000
| – | – | 0.01% | 576 |
|
|
2019
Q4 | $973K | Hold |
9,000
| – | – | 0.01% | 611 |
|
|
2019
Q3 | $881K | Buy |
9,000
+2,000
| +29% | +$196K | 0.01% | 627 |
|
|
2019
Q2 | $917K | Hold |
7,000
| – | – | 0.01% | 622 |
|
|
2019
Q1 | $946K | Buy |
7,000
+1,000
| +17% | +$135K | 0.01% | 588 |
|
|
2018
Q4 | $584K | Buy |
6,000
+1,000
| +20% | +$97.3K | ﹤0.01% | 618 |
|
|
2018
Q3 | $695K | Hold |
5,000
| – | – | ﹤0.01% | 635 |
|
|
2018
Q2 | $621K | Sell |
5,000
-1,000
| -17% | -$124K | ﹤0.01% | 654 |
|
|
2018
Q1 | $669K | Hold |
6,000
| – | – | ﹤0.01% | 629 |
|
|
2017
Q4 | $718K | Buy |
6,000
+2,000
| +50% | +$239K | ﹤0.01% | 625 |
|
|
2017
Q3 | $561K | Hold |
4,000
| – | – | ﹤0.01% | 670 |
|
|
2017
Q2 | $487K | Buy |
+4,000
| New | +$487K | ﹤0.01% | 695 |
|
|
2015
Q3 | – | Sell |
-1,415
| Closed | -$256K | – | 846 |
|
|
2015
Q2 | $256K | Buy |
+1,415
| New | +$256K | ﹤0.01% | 768 |
|